Stock TCRX TSCAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart TScan Therapeutics, Inc.

Equities

TCRX

US89854M1018

Real-time Estimate Cboe BZX
Other stock markets
 09:49:54 2024-06-13 am EDT 		5-day change 1st Jan Change
9.195 USD +3.55% Intraday chart for TScan Therapeutics, Inc. +1.15% +50.26%
May. 29 TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status MT
May. 29 TScan Therapeutics Receives FDA?s Regenerative Medicine Advanced Therapy Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TSCAN THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-0.34%+1.15%+50.26%+229.32% - 469M
Neutral
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. TCRX Stock
  4. Charts TScan Therapeutics, Inc.
  5. Comparison Chart